
Here is how Aveanna Healthcare (AVAH) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, offers private duty nursing (PDN) services, adult home health and palliative care, pediatric home therapy, and enteral nutrition services in the United States. The company is headquartered in Atlanta, Georgia.
| Revenue (TTM) | $2.60B |
| Gross Profit (TTM) | $833.88M |
| EBITDA | $311.23M |
| Operating Margin | 12.60% |
| Return on Equity | 198.60% |
| Return on Assets | 9.69% |
| Revenue/Share (TTM) | $12.24 |
| Book Value | $1.32 |
| Price-to-Book | 9.69 |
| Price-to-Sales (TTM) | 1.03 |
| EV/Revenue | 1.614 |
| EV/EBITDA | 13.82 |
| Quarterly Earnings Growth (YoY) | 38.50% |
| Quarterly Revenue Growth (YoY) | 13.70% |
| Shares Outstanding | $218.29M |
| Float | $104.42M |
| % Insiders | 5.64% |
| % Institutions | 94.12% |
Volatility is currently contracting

Here is how Aveanna Healthcare (AVAH) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.

Investors need to pay close attention to AVAH stock based on the movements in the options market lately.

Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by aging demographics, rising medical demand, and increased spending that's expected to outpace the broader economy. Strong forward revenue, EBITDA, and earnings growth demonstrate how select healthcare services and facilities companies can significantly outperform their sector peers.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Aveanna (AVAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here is how Aveanna Healthcare (AVAH) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Top-ranked stocks AVAH, FTNT, THC, ARW and VLO are likely to beat on the bottom line in their upcoming releases.

Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AVAH and any ticker you trade — then tracks every position and per-strategy win rate.